Clearside Biomedical Inc.

0.90
-0.02 (-1.95%)
At close: Apr 01, 2025, 3:59 PM
0.91
1.45%
After-hours: Apr 01, 2025, 07:55 PM EDT

Clearside Biomedical Income Statement

Year FY24 FY23 FY22 FY21 FY20
Revenue n/a 8.23M 1.33M 29.57M 7.89M
Cost of Revenue n/a 355K 204K 178K n/a
Gross Profit n/a 7.87M 1.12M 29.4M 7.89M
Operating Income -28.88M -24.84M -30.28M -627K -17.93M
Interest Income 1.46M n/a 669K n/a 335K
Pretax Income -34.35M -32.48M -32.95M 376K -18.21M
Net Income -34.35M -32.48M -34.07M 376K -18.03M
Selling & General & Admin 11.81M 11.87M 11.77M 11.66M 10.76M
Research & Development 18.59M 20.85M 19.63M 18.54M 15.07M
Other Expenses 149K n/a 669K 1M -275K
Operating Expenses 30.55M 32.72M 31.4M 30.2M 25.83M
Interest Expense -9.78M 9.36M 3.34M n/a 335K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses n/a 33.07M 31.6M 30.2M 25.83M
Income Tax n/a n/a 1.12M -58.56K -180K
Shares Outstanding (Basic) 73.8M 61.81M 60.2M 58.49M 46.51M
Shares Outstanding (Diluted) 73.8M 61.81M 60.2M 59.91M 46.51M
EPS (Basic) -0.47 -0.53 -0.57 0.01 -0.39
EPS (Diluted) n/a n/a n/a n/a n/a
EBITDA -28.88M -23.06M -29.46M -449K -17.93M
Depreciation & Amortization n/a 67K 145K 178K 180K